SNAPSHOT: WHY NOVEL MULTIPLEXED MOLECULAR DIAGNOSTICS MATTERS?
January 31, 2024
Today, across clinical testing demands, there are instances where diagnostic pathogen testing conducted through well-known qPCR (quantitative polymerase chain reaction) and NGS (next-generation genomic sequencing) can be better addressed by new technology. PathogenDx innovation has produced Dynamic Dimensional Detection through its novel D3 Array™ platform.
How does this third path to insight that address sensitivity and multiplex limitation of qPCR and improve on the cost and timeliness of NGS? Download our Innovation Snapshot for a quick overview of this breakthrough technology. Better still, reach out to arrange a technical webinar for how assays designed upon the D3 Array™ are driving laboratory efficiencies, reducing cost and waste, and showing the way to improve lab testing economics.Back »